Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227194 · ClinicalTrials.gov registry record
Machine Learning Assessment of Next-Day Migraine Likelihood
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 53,065
- Enrollment target
NCT07227194 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 53,065 participants.
The verdict
NCT07227194 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 53,065 participants
- Enrollment target
Study Summary
Development of a machine learning (ML) algorithm for assessment of next-day migraine likelihood, drawing on self-reported migraine-related information, and geographic location, collected via the Nerivio app- a mobile application used for migraine treatment by the Remote Electrical Neuromodulation (REN) wearable device.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53,065 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2025-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227194
The ClinicalTrials.gov registry entry for NCT07227194 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53,065 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07227194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07227194 about?
NCT07227194 is a clinical study titled "Machine Learning Assessment of Next-Day Migraine Likelihood". Development of a machine learning (ML) algorithm for assessment of next-day migraine likelihood, drawing on self-reported migraine-related information, and geographic location, collected via the Nerivio app- a mobile application used for migraine treatment by the Remote Electrical Neuromodulation (R...
What is the current status of trial NCT07227194?
This trial is currently completed. The enrollment target is 53,065 participants. The study started on 2025-02-07. Estimated completion is 2025-08-20.
Who is sponsoring clinical trial NCT07227194?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.